AAAAAA

   
Results: 1-3 |
Results: 3
A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS
Authors: RIVERA E CHEVLEN E ECKARDT J KENNEDY MJ SAWHNEY R SUTTON L FRYE D HEDRICK J MCGUIRT C LEVIN J HOHNEKER J WHITE R HORTOBAGYI GN
Citation: E. Rivera et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY ORAL REGIMEN OF 5-FLUOROURACIL (5-FU) PLUS ENILURACIL FOR THE TREATMENT OF PATIENTS WITH TAXANE AND ANTHRACYCLINE-RESISTANT ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 70-70
A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC)
Authors: LOKICH J BECK T CHEVLEN E HOCHSTER H OROURKE M WEAVER C BELL W MCGUIRT C LEVIN J HOHNEKER J MANI S
Citation: J. Lokich et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 169-169
DOSE-INTENSIVE VINORELBINE WITH CONCURRENT GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN PACLITAXEL-REFRACTORY METASTATIC BREAST-CANCER
Authors: LIVINGSTON RB ELLIS GK GRALOW JR WILLIAMS MA WHITE R MCGUIRT C ADAMKIEWICZ BB LONG CA
Citation: Rb. Livingston et al., DOSE-INTENSIVE VINORELBINE WITH CONCURRENT GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN PACLITAXEL-REFRACTORY METASTATIC BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1395-1400
Risultati: 1-3 |